Home › Funds › Velan Capital Investment Management LP › RNTX

Velan Capital Investment Management LP position in RNTX

REIN THERAPEUTICS INC · Health Care

Velan Capital Investment Management LP reported holding 1,700,000 shares of RNTX (REIN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.30% of its reported portfolio and ranking #15 among its reported holdings. Velan Capital Investment Management LP has disclosed RNTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.70M sh
Reported value held$1.37M
Portfolio Weight1.30%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's RNTX position evolved

Velan Capital Investment Management LP first disclosed a stake in RNTX in Q2 2026 at 1,700,000 shares (US$1.8M). Across 2 filings, Velan Capital Investment Management LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,700,000 shares valued at US$1.4M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.70M $1.77M New
Q3 2026 1.70M $1.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RNTX and 13F data

RNTX (REIN THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in RNTX — the largest reported positions include BIOS Capital Management, LP (US$2.40B), Voss Capital, LP (US$5.5M), Cable Car Capital, LP (US$5.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RNTX

All RNTX fund holders →

FAQ

How long has Velan Capital Investment Management LP held RNTX?

Velan Capital Investment Management LP has disclosed RNTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Velan Capital Investment Management LP's current position in RNTX?

As of Q3 2026, Velan Capital Investment Management LP holds 1.70M shares of RNTX (REIN THERAPEUTICS INC), valued at $1.37M, representing 1.30% of its reported portfolio and ranking #15.

Has Velan Capital Investment Management LP been buying or selling RNTX?

In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in RNTX.

Which other funds hold RNTX?

Other major institutional holders of RNTX include BIOS Capital Management, LP, Voss Capital, LP, Cable Car Capital, LP, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.